ChiCTR-IIR-17014018: The clinical research of safety and effectiveness of Tobrdex (0.3% and 0.1% tobramycin dexamethasone ophthalmic suspension) as control, Zylet (0.5% loteprednol and 0.3% tobramycin ophthalmic suspension) treatment blepharo-keratoconjunctivitis |
|
|
| Completed | 1 | 344 | | Zylet (0.5% loteprednol and 0.3% tobramycin ophthalmic suspension) ;Tobrdex (0.3% and 0.1% tobramycin dexamethasone ophthalmic suspension) | Eye Hospital of Wenzhou Medical University; Bausch & Lomb Limited by Share Ltd, company | blepharo-keratoconjunctivitis | | | | |
NCT06175676: Safety and Efficacy of Thermosensitive Hydroxybutyl Chitosan and 5-fluorouracil Assisted Endoscopic Dacryocystorhinostomy in the Treatment of Chronic Dacryocystitis |
|
|
| Completed | 1 | 90 | RoW | Hydroxybutyl chitosan, 5-Fluorouracil, Gelatin Sponge Sheet | Tianjin Medical University Eye Hospital | Dacryocystorhinostomy, Hydroxybutyl Chitosan, Fluorouracil, Chronic Dacryocystitis | 06/23 | 12/23 | | |
